Market Research Logo

DNA Sequencing: Emerging Technologies and Applications

DNA Sequencing: Emerging Technologies and Applications

The global market for sequencing products has grown to $5.9 billion in 2015 from $5.3 billion in 2014. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 18.7% from 2015 to 2020, reaching nearly $13.8 billion by 2020.

This report provides:
An in-depth analysis of the sequencing industry, an important industry in life sciences with enormous market potential.
Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
Quantification of the DNA sequencing markets by product type, platform, customer type, value chain position, analysis type and geography.
A look at substantial future growth opportunities for industry participants including consumer and diagnostic sequencing services, bioinformatics, sequence enrichment, benchtop NGS sequencers and consumables, and emerging sequencing instruments.
Comprehensive discussion covering sequencing technologies, market applications, industry structure, and important clinical sequencing initiatives.
A relevant patent analysis.
Profiles of major players in the sequencing industry.


SCOPE AND FORMAT OF REPORT

The scope of the report includes sequencing technologies, applications, industries, initiatives, markets, patents and companies. The markets for sequencing products and services are given for the years 2014, 2015 and 2020.

This report reviews the main sequencing platforms, and explains why genetic variation is important for many applications, including clinical testing. It then discusses some of the top research initiatives that are contributing to sequencing markets. Industry market driving forces are also discussed.

The report covers the sequencing markets by workflow, including sample preparation products; sequencing instruments and consumables; informatics; and sequencing services. It includes the sequencing instrument market by platform: Sanger and next-generation technologies, and by instrument class: low-throughput, high-throughput, benchtop and handheld.

The report covers the markets for the main sequencing end-use applications, including research (R&D, drug discovery and development, biotech); clinical; and applied (consumer, forensics, microbial genomics, agricultural genomics).

The report covers the sequencing clinical markets, including by test complexity, indication and test purpose. Test complexity refers to the multiplexing (e.g., the number of genes covered) and coverage (e.g., the extent to which the genome is covered) of the test. Examining the market by test complexity provides valuable insight into which products (e.g., sample preparation, sequencing instrument, informatics) will be in demand in the future.

The report provides market data and forecasts for sequencing-based diagnostics by specific applications, including those for cancer, rare diseases, common diseases, transplant and reproductive health.

The specific geographic markets discussed include North America, Europe, Asia-Pacific and the rest of the world.

Market data covers the years 2014, 2015 and 2020.

The report analyzes specific sequencing-related industries, including next-generation sequencing instruments (including market share data for the main instrument companies); droplet digital PCR; target enrichment and amplification; specialist DNA polymerase; noninvasive prenatal testing (including market share data for the leading companies); preimplantation genetic diagnosis and screening; liquid biopsy; immune sequencing; informatics industry; and human leukocyte antigen (HLA) typing industry.

More than 225 companies in the sequencing industry are profiled in this report.

BCC Research provides a summary of the main industry acquisitions and strategic alliances from 2014 through early 2016, including key alliance trends.

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE AND FORMAT OF REPORT
METHODOLOGY
INFORMATION SOURCES
RELATED BCC RESEARCH REPORTS
ANALYST'S CREDENTIALS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL SEQUENCING MARKET BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
SUMMARY FIGURE GLOBAL SEQUENCING MARKET BY PRODUCT TYPE, 2014-2020 ($ MILLIONS)
CHAPTER 3 OVERVIEW
INTRODUCTION
TABLE 1 ARRAY OF WORKFLOW PRODUCTS AND SERVICES
SEQUENCING MARKET
TABLE 2 GLOBAL SEQUENCING MARKET BY DELIVERED FORMAT, THROUGH
2020 ($ MILLIONS)
TABLE 3 KEY DRIVING FORCES FOR SEQUENCING INDUSTRY GROWTH
SEQUENCING PRODUCTS
SEQUENCING INSTRUMENTS AND CONSUMABLES
SAMPLE PREPARATION REAGENTS AND KITS
BIOINFORMATICS
SEQUENCING SERVICES
SEQUENCING PRODUCT LIFE CYCLE STATUS
TABLE 4 LIFE CYCLE OF DNA SEQUENCING TYPES
NEXT-GENERATION SEQUENCING INDUSTRY
TABLE 5 SUMMARY OF NEXT-GENERATION SEQUENCING INDUSTRY
SECTORS
CHAPTER 4 TECHNOLOGIES
IMPORTANCE OF DNA
TABLE 6 DNA CHEMICAL BUILDING BLOCKS
TABLE 7 PROCESS OF DNA TRANSLATION AND TRANSCRIPTION
TABLE 8 LONG-RANGE DNA STRUCTURE
GENETIC VARIATION AND ANALYSIS
TABLE 9 DIFFERENT TYPES OF GENETIC VARIANTS
GENETIC ANALYSIS TECHNOLOGIES
TABLE 10 IMPORTANT MOLECULAR DIAGNOSTIC PLATFORMS, BY COMPANY
SEQUENCING IN CLINICAL APPLICATIONS
TABLE 11 EVOLUTION OF GENETIC TESTING
TABLE 12 KEY NEAR- TO MID-TERM SEGMENTS FOR NEXT-GENERATION
SEQUENCING DIAGNOSTICS
SEQUENCING TECHNOLOGIES
HISTORY OF DNA SEQUENCING
TABLE 13 HISTORICAL TIMELINE OF DNA SEQUENCING
TABLE 14 SEQUENCING TECHNOLOGY DEVELOPMENT, 1990-2020
TABLE 15 COST TO SEQUENCE A SINGLE HUMAN GENOME, 2001-2015 ($)
SANGER SEQUENCING TECHNOLOGY
TABLE 16 SANGER SEQUENCING SUMMARY
TABLE 17 SANGER SEQUENCING IMPROVEMENTS
NEXT-GENERATION SEQUENCING PLATFORMS
TABLE 18 NEXT-GENERATION SEQUENCING TECHNOLOGIES
TABLE 19 ROCHE NEXT-GENERATION SEQUENCING WORKFLOW STEPS
TABLE 20 ILLUMINA NEXT-GENERATION SEQUENCING WORKFLOW STEPS
TABLE 21 LIFE TECHNOLOGIES NEXT-GENERATION SEQUENCING
WORKFLOW STEPS
BENCHTOP SEQUENCERS
TABLE 22 BENCHTOP AND HANDHELD SEQUENCER PLATFORMS, 2010-2015
INFORMATICS TECHNOLOGIES
TABLE 23 NEXT-GENERATION SEQUENCING BIOINFORMATICS WORKFLOW
BASE CALLING
MAPPING TO A REFERENCE SEQUENCE
TABLE 24 SEQUENCE ANNOTATION STEPS
VARIANT ANALYSIS
CLINICAL SEQUENCING TECHNOLOGY CHALLENGES
TABLE 25 FUTURE CHALLENGES FOR IMPLEMENTING CLINICAL
NEXT-GENERATION SEQUENCING
CLINICAL NGS INITIATIVES
TABLE 26 KEY CLINICAL NGS PROJECTS
100K GENOMES PROJECT
ACTIONABLE GENOME CONSORTIUM
BABYSEQ
CANCER MOON SHOTS PROGRAM
CLINGEN
CSER
DECIPHERING DEVELOPMENTAL DISORDERS PROJECT
EMERGE
GENOME KOREA
LUNG-MAP
MATCHMAKER EXCHANGE
MILLION VETERAN PROGRAM
MEDSEQ
PRECISION MEDICINE
PROMPT
UK10K
CHAPTER 5 DNA SEQUENCING APPLICATIONS
INTRODUCTION
TABLE 27 GENOME SEQUENCING PROJECTS, 2005 AND 2015
GENETIC ANALYSIS
TABLE 28 COMPARISON OF GENETIC ANALYSIS FORMATS
TABLE 29 APPLICATIONS OF SEQUENCING ANALYSIS
TABLE 30 REQUIREMENTS FOR DE NOVO VS. RESEQUENCING
DE NOVO WHOLE GENOME SEQUENCING
RESEQUENCING
WHOLE GENOME RESEQUENCING
TARGETED RESEQUENCING
SEQ-BASED METHODS
TABLE 31 GENETIC ANALYSIS APPLICATIONS UTILIZING MICROARRAYS OR SEQUENCING PLATFORMS
CHIPSEQ
TABLE 32 COMPARISON OF SEQUENCING WITH MICROARRAYS FOR CHIP
APPLICATIONS
DNASE-SEQ
RNA-SEQ
TABLE 33 COMPARISON OF SEQUENCING AND MICROARRAYS FOR GENE
EXPRESSION ANALYSIS
METHYL-SEQ
STRUCTURAL VARIATION STUDIES
COMPLEMENTARY SEQUENCING AND MICROARRAY PLATFORMS
SEQUENCING END-USE APPLICATIONS
RESEARCH
CONSUMER SEQUENCING
TABLE 34 COMPARISON OF GENETIC ANALYSIS PLATFORMS
AGRICULTURAL SEQUENCING
TABLE 35 IMPACT OF SEQUENCING ON AGRICULTURAL PRODUCT
CLASSES
MICROBIAL SEQUENCING
TABLE 36 KEY APPLICATIONS IN MICROBIAL SEQUENCING
FORENSICS SEQUENCING
TABLE 37 KEY APPLICATIONS IN FORENSICS/HUMAN IDENTITY
SEQUENCING
CHAPTER 6 CLINICAL SEQUENCING APPLICATIONS
INTRODUCTION
TABLE 38 CLINICAL NEXT-GENERATION SEQUENCING, NEAR-TO MID-TERM
APPLICATIONS
CANCER APPLICATIONS
TABLE 39 MAJOR CANCER APPLICATIONS FOR NGS DIAGNOSTICS
MENDELIAN DISORDERS APPLICATION
TABLE 40 MENDELIAN DISORDERS APPLICATION
REPRODUCTIVE HEALTH APPLICATIONS
TABLE 41 SCREENING APPLICATIONS
TABLE 42 ETHICAL ISSUES ASSOCIATED WITH PRENATAL AND NEWBORN
SCREENING
INFECTIOUS DISEASE APPLICATIONS
TABLE 43 INFECTIOUS DISEASE APPLICATIONS
COMPLEX DISORDERS APPLICATIONS
TABLE 44 COMPLEX DISORDERS APPLICATIONS
CHAPTER 7 SEQUENCING INDUSTRY
INTRODUCTION
TABLE 45 KEY SEGMENTS AND TRENDS IN THE SEQUENCING INDUSTRY
NGS INSTRUMENT INDUSTRY
TABLE 46 NEXT-GENERATION SEQUENCING INSTRUMENT COMPANIES
DROPLET DIGITAL PCR INDUSTRY
TABLE 47 ADVANTAGES OF DROPLET DIGITAL PCR
TABLE 48 DROPLET DIGITAL PCR INDUSTRY
TARGET ENRICHMENT AND AMPLIFICATION INDUSTRY
TABLE 49 TARGET ENRICHMENT INDUSTRY
SPECIALIZED DNA POLYMERASE INDUSTRY
TABLE 50 SPECIALIZED DNA POLYMERASE INDUSTRY
NONINVASIVE PRENATAL TESTING INDUSTRY
TABLE 51 KEY COMPANIES IN THE NGS NIPT INDUSTRY
TABLE 52 GLOBAL NIPT MARKET BY REGION, COMPANY AND NUMBER OF TESTS, 2015
TABLE 53 GERMAN COMPANIES INVOLVED IN NGS-BASED NONINVASIVE
PRENATAL DIAGNOSTICS
PREIMPLANTATION GENETICS DIAGNOSIS AND SCREENING INDUSTRY
TABLE 54 PREIMPLANTATION DIAGNOSTICS PLATFORMS
TABLE 55 PREIMPLANTATION GENETIC SCREENING AND DIAGNOSIS
INDUSTRY
LIQUID BIOPSY INDUSTRY
TABLE 56 COMPANIES IN THE LIQUID BIOPSY INDUSTRY AND THEIR FOCUS
IMMUNE SYSTEM PROFILING INDUSTRY
TABLE 57 COMPANIES IN THE IMMUNE SYSTEM PROFILING INDUSTRY
NEXT-GENERATION SEQUENCING CLINICAL INFORMATICS INDUSTRY
TABLE 58 NEXT-GENERATION SEQUENCING CLINICAL INFORMATICS
COMPANY POSITIONING
HLA TYPING INDUSTRY
TABLE 59 NGS-BASED HLA TYPING INDUSTRY COMPANIES
THIRD-GENERATION SEQUENCING INDUSTRY
TABLE 60 SUMMARY OF 3GS INDUSTRY
DIRECT-TO-CONSUMER GENETIC TESTING INDUSTRY
TABLE 61 KEY COMPANIES IN THE DIRECT-TO-CONSUMER GENETIC
TESTING INDUSTRY
ACQUISITIONS AND STRATEGIC ALLIANCES
SEQUENCING INDUSTRY ACQUISITIONS
TABLE 62 SEQUENCING INDUSTRY ACQUISITIONS 2014-2015
SEQUENCING INDUSTRY STRATEGIC ALLIANCES
TABLE 63 SEQUENCING INDUSTRY STRATEGIC ALLIANCES 2014-2016
CHAPTER 8 SEQUENCING MARKETS
FORCES DRIVING GROWTH
TABLE 64 KEY DRIVERS OF GROWTH FOR THE SEQUENCING INDUSTRY
SEQUENCING MARKET SUMMARY
TABLE 65 GLOBAL SEQUENCING MARKET BY DELIVERED FORMAT, THROUGH 2020 ($ MILLIONS)
SEQUENCING INSTRUMENTS AND CONSUMABLES MARKET
TABLE 66 GLOBAL MARKET FOR SEQUENCING INSTRUMENTS AND CONSUMABLES BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
SEQUENCING INSTRUMENTS AND CONSUMABLES BY PLATFORM
TABLE 67 GLOBAL MARKET FOR SEQUENCING INSTRUMENTS AND CONSUMABLES BY PLATFORM, THROUGH 2020 ($ MILLIONS)
TABLE 68 COMPANIES MIGRATING TO NGS FOR HIV TESTING
NGS INSTRUMENTS AND CONSUMABLES BY PLATFORM
TABLE 69 GLOBAL MARKET FOR SEQUENCING INSTRUMENTS AND CONSUMABLES BY SEQUENCER PLATFORM, THROUGH 2020 ($ MILLIONS)
SEQUENCING SAMPLE PREP MARKET
TABLE 70 GLOBAL SEQUENCING SAMPLE PREP MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
SEQUENCING INFORMATICS MARKET
TABLE 71 GLOBAL SEQUENCING INFORMATICS MARKET BY SOFTWARE FUNCTION, THROUGH 2020 ($ MILLIONS)
SEQUENCING SERVICES MARKET
TABLE 72 GLOBAL SEQUENCING SERVICES MARKET BY END USER, THROUGH 2020 ($ MILLIONS)
SEQUENCING SERVICES MARKET BY GENOME TYPE
TABLE 73 GLOBAL SEQUENCING SERVICES MARKET BY GENOME TYPE, THROUGH 2020 ($ MILLIONS)
APPLIED SEQUENCING SERVICES MARKET
TABLE 74 GLOBAL MARKET FOR APPLIED SEQUENCING SERVICES BY APPLICATION, THROUGH 2020 ($ MILLIONS)
Agriculture Sequencing
Consumer Sequencing
Forensics Sequencing
Microbiology Sequencing
TABLE 75 GLOBAL AGRICULTURE SEQUENCING SERVICES MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
TABLE 76 SEQUENCING IMPACT ON AGRICULTURAL PRODUCT
CLASSES
CLINICAL SEQUENCING MARKET
TABLE 77 GLOBAL CLINICAL SEQUENCING MARKET BY INDICATION, THROUGH 2020
TABLE 78 GLOBAL CLINICAL SEQUENCING MARKET BY TEST COMPLEXITY, THROUGH 2020 ($ MILLIONS)
TABLE 79 GLOBAL CLINICAL SEQUENCING MARKET BY TEST PURPOSE, THROUGH 2020 ($ MILLIONS)
CLINICAL SEQUENCING CANCER MARKET
TABLE 80 GLOBAL CLINICAL SEQUENCING CANCER MARKET BY INDICATION, THROUGH 2020 ($ MILLIONS)
TABLE 81 GLOBAL CLINICAL SEQUENCING CANCER MARKET BY TEST PURPOSE, THROUGH 2020 ($ MILLIONS)
TABLE 82 SCREENING METHODS FOR EARLY CANCER DETECTION
TABLE 83 GLOBAL CLINICAL SEQUENCING CANCER MARKET BY TEST COMPLEXITY, THROUGH 2020 ($ MILLIONS)
REPRODUCTIVE HEALTH MARKET
TABLE 84 GLOBAL MARKET FOR REPRODUCTIVE HEALTH SEQUENCING BY TEST APPLICATION, THROUGH 2020 ($ MILLIONS)
NIPT MARKET
TABLE 85 GLOBAL NIPT MARKET BY RISK TYPE, THROUGH 2020 ($ MILLIONS)
IVF MARKET
NEWBORN SCREENING MARKET
CARRIER SCREENING MARKET
TABLE 86 GLOBAL REPRODUCTIVE HEALTH SEQUENCING MARKET BY TEST COMPLEXITY, THROUGH 2020 ($ MILLIONS)
TRANSPLANT MARKET
TABLE 87 GLOBAL TRANSPLANT SEQUENCING MARKET BY TEST PURPOSE, THROUGH 2020 ($ MILLIONS)
TABLE 88 GLOBAL TRANSPLANT SEQUENCING MARKET BY TEST COMPLEXITY, THROUGH 2020 ($ MILLIONS)
TABLE 89 GLOBAL MARKET FOR SEQUENCING TRANSPLANT MONITORING BY ORGAN TYPE, THROUGH 2020 ($ MILLIONS)
TABLE 90 TRANSPLANT PROCEDURES PERFORMED IN THE U.S., 2015
MICROBIOLOGY MARKET
TABLE 91 GLOBAL MICROBIOLOGY SEQUENCING MARKET BY END USER, THROUGH 2020 ($ MILLIONS)
INFORMATICS MARKET
TABLE 92 GLOBAL INFORMATICS SEQUENCING MARKET BY SOFTWARE FUNCTION, THROUGH 2020 ($ MILLIONS)
REGIONAL MARKET
TABLE 93 GLOBAL SEQUENCING MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 94 GLOBAL CANCER DIAGNOSTICS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 95 GLOBAL MARKET FOR REPRODUCTIVE HEALTH SEQUENCING BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 96 GLOBAL TRANSPLANT DIAGNOSTICS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
CHAPTER 9 SEQUENCING PATENTS
CLINICAL NGS PATENTS
TABLE 97 CLINICAL NEXT-GENERATION SEQUENCING PATENTS, 2005-2015 (NO. OF PATENTS)
CLINICAL NGS PATENTS BY INDICATION
TABLE 98 CLINICAL NEXT-GENERATION SEQUENCING PATENTS BY INDICATION, 2005-2015
CELL-FREE DNA PATENTS
TABLE 99 CELL-FREE DNA PATENTS BY REGION, 2005-2015
SEQUENCING-RELATED PATENT ISSUES
TABLE 100 STATUS OF SEQUENCING-RELATED PATENT DISPUTES
CHAPTER 10 COMPANY PROFILES
10X GENOMICS
23ANDME INC.
TABLE 101 23ANDME DATA NEEDS
ACCURAGEN
ADAPTIVE BIOTECHNOLOGIES INC.
ADICON CLINICAL LABORATORIES
ADMERA HEALTH
AGILENT TECHNOLOGIES INC.
ALMAC GROUP LTD.
ALTHEA DX
AMARANTUS BIOSCIENCE HOLDINGS INC.
TABLE 102 MULTIPLE SCLEROSIS DIAGNOSTIC WORKFLOW
AMBRY GENETICS
ANNOROAD GENE TECHNOLOGY
APPISTRY INC.
ARCHERDX
ARUP LABORATORIES
ASTRIDBIO TECHNOLOGIES KFT.
ASSUREX HEALTH
ASURAGEN INC.
ATHENA DIAGNOSTICS INC.
ATRECA INC.
BASE4 INNOVATION LTD.
BAYLOR MIRACA GENETICS LABORATORIES INC.
BECTON, DICKINSON AND CO.
BECKMAN COULTER
BERRY GENOMICS CO. LTD.
BGI SHENZHEN
BIOCARTIS NV
BIOCEPT INC.
BIO.LOGIS GMBH
BIOINNOVATION SOLUTIONS
BIOMATTERS LTD.
BIO-RAD LABORATORIES INC.
BIOTHERANOSTICS INC.
BLUEPRINT GENETICS
BOREAL GENOMICS
CAMBRIDGE EPIGENETIX LTD.
TABLE 103 COMPANIES IN THE EPIGENETIC SEQUENCING INDUSTRY
CAREDX INC.
CARIS LIFE SCIENCES
CEGAT GMBH
CELL MICROSYSTEMS INC.
CELLULAR RESEARCH INC.
CELSEE DIAGNOSTICS
CENTOGENE AG
CERGENTIS BV
CHRONIX BIOMEDICAL
CIRCULOGENE THERANOSTICS
CLARITAS GENOMICS INC.
CLONTECH LABORATORIES INC.
COFACTOR GENOMICS INC.
COLOR GENOMICS
CORIELL LIFE SCIENCES INC.
CORRELAGEN DIAGNOSTICS INC.
COUNSYL INC.
COURTAGEN LIFE SCIENCES INC.
CYNVENIO BIOSYSTEMS INC.
DANAHER CORP.
DARUI BIOTECHNOLOGY CO. LTD.
DIAGNOMICS
DIAN DIAGNOSTICS
DIPLOID
DNA ELECTRONICS LTD.
DNA LINK INC.
DNANEXUS INC.
EAGLE GENOMICS LTD.
ELECTRONIC BIOSCIENCES
EPIC SCIENCES
ESPERITE NV
EUROFINS GENOMICS
EXIQON A/S
EXOSOME DIAGNOSTICS INC.
EXPRESSION ANALYSIS INC.
FOUNDATION MEDICINE
FLUXION BIOSCIENCES INC.
FULL GENOMES CORP.
FUSION GENOMICS CORP.
GATC BIOTECH AG
GE HEALTHCARE
GENAPSYS INC.
GENDX BV
GENE BY GENE LTD.
GENEDX INC.
GENEPEEKS INC.
GENEWIZ INC.
GENOMATIX SOFTWARE GMBH
GENOMEDX BIOSCIENCES
GENOMIC EXPRESSION
GENOMIC HEALTH INC.
GENOME PROFILING LLC
GENOMNIA SRL
GENOMONCOLOGY
GENOSPACE
GIGAGEN INC.
GOOD START GENETICS INC.
GOLDEN HELIX
GRAIL
GUARDANT HEALTH INC.
GUARDIOME
HELIX OPCO LLC
HISTOGENETICS LLC
HTG MOLECULAR DIAGNOSTICS INC.
HUMAN LONGEVITY INC.
ILLUMINA INC.
TABLE 104 NEW PLATFORMS INTRODUCED BY ILLUMINA, 2015
INTELLIMEDIX
INTERPACE DIAGNOSTICS LLC
TABLE 105 MOLECULAR THYROID NODULE CLASSIFIER TEST COMPANY
POSITIONING
INVITAE
INVIVOSCRIBE TECHNOLOGIES INC.
IREPERTOIRE INC.
KAILOS GENETICS
KAPA BIOSYSTEMS INC.
KELLBENX INC.
KEW GROUP INC.
KINGMED DIAGNOSTICS CENTER CO. LTD.
LABORATORY CORP. OF AMERICA INC.
LABORATORY FOR MOLECULAR MEDICINE
LASERGEN INC.
LEUCINE RICH BIO
LUMENOGIX INC.
MACROGEN INC.
MAPMYGENOME
MAVERIX BIOMICS INC.
MAYO MEDICAL LABORATORIES
MDX HEALTH INC.
MEDGENOME LABS PVT. LTD.
MEDOMICS LLC
MERCK KGAA
MICROSYNTH AG
MIINOME INC.
MIRATI THERAPEUTICS
MOGENE DX
MOLECULAR HEALTH GMBH
MOLECULARMD CORP.
MRIGLOBAL RESEARCH INSTITUTE
MULTIPLICOM NV
MYRIAD GENETICS INC.
NATERA INC.
NEOGENOMICS INC.
NEW ENGLAND BIOLABS
NEWGENE LTD.
NEW ONCOLOGY AG
N-OF-ONE INC.
NOVARTIS AG
NOVOGENE BIOINFORMATICS TECHNOLOGY CO. LTD.
NUGEN TECHNOLOGIES INC.
NXT-DX
OMICIA INC.
OMIXON BIOCOMPUTING KFT
ONCODNA SA
ONCOSPIRE GENOMICS
ONEOME
OXFORD GENE TECHNOLOGY
OXFORD NANOPORE TECHNOLOGIES LTD.
PACIFIC BIOSCIENCES OF CALIFORNIA INC.
PAIRNOMIX INC.
PARABASE GENOMICS
PARSEQ LAB
PATHWAY GENOMICS CORP.
PERKINELMER INC.
PERSONAL GENOME DIAGNOSTICS INC.
PERSONAL GENOMICS INC.
PERSONALIS INC.
PICOSEQ
POPULATION GENETICS TECHNOLOGIES LTD.
TABLE 106 SENSITIVITY TO DETECT DRUG-RESISTANT MUTATIONS IN VIRUSES (%)
PORTABLE GENOMICS LLC
POSITIVE BIOSCIENCE
PREMAITHA HEALTH PLC
PRENETICS
PRESSURE BIOSCIENCES INC.
PREVENTIONGENETICS INC.
QIAGEN NV
QUANTAPORE INC.
QUANTUMDX
QUEST DIAGNOSTICS
RAINDANCE TECHNOLOGIES INC.
RARECELLS SAS
RARECYTE INC.
REAL TIME GENOMICS INC.
REPROGENETICS
RESOLUTION BIOSCIENCE INC.
ROCHE HOLDING AG
TABLE 107 COMMERCIAL SEQUENCER COMPETITIVE POSITIONING
RUBICON GENOMICS
SALVEO DX
SCREENCELL
SCIGENOM LABS
SELAH GENOMICS
SENGENICS INTERNATIONAL PTE LTD.
SEQUENOM INC.
SEVEN BRIDGES GENOMICS INC.
SILICON BIOSYSTEMS
SISTEMAS GENOMICOS SL
SOFTGENETICS LLC
SOPHIA GENETICS
SPIRAL GENETICS INC.
STATION X INC.
STRAND LIFE SCIENCES
STRATEC BIOMEDICAL AG
STRATOS GENOMICS INC.
SUNDANCE DIAGNOSTICS INC.
SURE GENOMICS INC.
SYAPSE INC.
SYGNIS AG
SYMBIODX
SYSMEX INOSTICS GMBH
TAI DIAGNOSTICS INC.
THERMO FISHER SCIENTIFIC INC.
THORNE DIAGNOSTICS INC.
TRANSGENOMIC INC.
TROVAGENE INC.
TUTE GENOMICS INC.
TWO PORE GUYS INC.
UBIQUITY GENOMICS INC.
VELA DIAGNOSTICS
WAFERGEN BIO-SYSTEMS INC.
TABLE 108 WAFERGEN STRATEGIC ALLIANCES
WARP DRIVE BIO LLC
XCELL BIOSCIENCES INC.
YIKON GENOMICS CO. LTD.
ZINXIN PHARMACEUTICAL INDUSTRIAL CO LTD.
ZS GENETICS INC.
ZYMO RESEARCH CORP.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report